Angel is a Post-Doctoral Fellow working with Dr. Michael Chan for the Novel experimental platform of human respiratory tract program.
What is your background?
After completing my master’s degree in Molecular Parasitology at the University of Manchester, I pursued my PhD in the Department of Pathology at the University of Hong Kong, where I explored the prospect of targeting dysregulated fatty acid metabolism to treat liver cancer.
What is your research interest?
My current research interests are to develop physiologically relevant
experimental models for screening therapeutic candidates, to investigate the pathogenesis of emerging infectious diseases, as well as to explore novel therapeutic options for virus-induced acute lung injury.
Working at C2i
At C2i, I am a Post-Doctoral Fellow working with Dr. Michael Chan for the Novel experimental platform of human respiratory tract program. My research mainly focuses on the therapeutic potential of mesenchymal stromal cells and their derivatives in promoting tissue regeneration following respiratory viral infections.